Pure Global

pH Quantitative Test Card, pCO2, pO2, Na (Sodium), K (Potassium), Ca (Calcium), Cl (Chloride), Hematocrit - Vietnam Registration 2400849ĐKLH/BYT-HTTB

Access comprehensive regulatory information for pH Quantitative Test Card, pCO2, pO2, Na (Sodium), K (Potassium), Ca (Calcium), Cl (Chloride), Hematocrit in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400849ĐKLH/BYT-HTTB and manufactured by Radiometer Medical ApS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400849ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400849ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

pH Quantitative Test Card, pCO2, pO2, Na (Sodium), K (Potassium), Ca (Calcium), Cl (Chloride), Hematocrit
VN: Thẻ xét nghiệm định lượng pH, pCO2, pO2, Na (Natri), K (Kali), Ca (Calci), Cl (Clorid), Hematocrit
Risk Class TTBYT Loại C

Registration Details

2400849ĐKLH/BYT-HTTB

000.00.04.G18-211110-0007

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Radiometer Medical ApS

Technical Details

The SC9 Sensor Cassette is an in vitro diagnostic medical device used with the ABL9 and SP9 Solution Pack. ABL9 is a portable, automated blood gas and electrolyte analyzer that measures pH, blood gas, electrolytes, lactate, and hematocrit in whole blood samples. The ABL9 blood gas and electrolyte analyzer is used by trained technicians, nurses, doctors, and clinical laboratories. The product is intended for use in point-of-care or hospital laboratory settings. ABL9 is an in vitro diagnostic medical device and is intended for use in quantitative testing to support clinical decision-making in the diagnosis of various disorders, including metabolic, respiratory, endocrine, hemolytic, cardiovascular, and infectious conditions in the general patient population.

Dates and Status

Jun 24, 2024